肺纤维化是以多种原因导致肺部炎症、组织结构破坏为特征的一大类肺疾病的终末期改变。作为“呼吸系统中的难治病”,其好发于中老年人,病程长、预后不佳,在治疗上,西医治疗方式、药物少,且价格昂贵,效果也不理想甚至副作用明显。中医药治疗“肺痹”、“肺痿”已有数百年的历史,在肺纤维化的治疗上有一定的基础,而“中医体质学说”是国医大师王琦院士近年来提出的一项新的概念,结合中医体质学说治疗肺纤维化,响应了“健康中国”策略的号召,推动中医药的发展。Pulmonary fibrosis is a major type of end-stage lung disease characterized by inflammation and tissue structure damage caused by various reasons. As a “difficult to treat disease in the respiratory system”, it is more common in middle-aged and elderly people, with a long disease course and poor prognosis. In terms of treatment, Western medicine has few treatment methods and drugs, and the price is expensive. The effect is not ideal and even the side effects are obvious. Traditional Chinese medicine has a history of hundreds of years in treating “pulmonary obstruction” and “pulmonary dysfunction”, and has a certain foundation in the treatment of pulmonary fibrosis. “Traditional Chinese Medicine constitution theory” is a new concept proposed by academician Wang Qi, a master of Chinese medicine, in recent years. Combining traditional Chinese medicine constitution theory to treat pulmonary fibrosis, it responds to the call of the “Healthy China” strategy and promotes the development of traditional Chinese medicine.
